INHA and tuberculosis: Although phenotypic drug susceptibility testing (DST) and genotypic predictions for MDR-TB were highly concordant (> 90%), our analysis of discordant cases revealed three putative novel markers for isoniazid (inhA I21M, katG K143E and D419Y).